Login / Signup

Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase).

Min-Taek LeeJu Won LeeHyeon Ji LeeJong-Min LeeJae Chol ChoiKang-Mo GuSun-Young Jung
Published in: BMJ open respiratory research (2023)
No significant signal of disproportionate reporting of ILD was observed for COVID-19 vaccines compared with all other vaccines. Moreover, when compared with the influenza vaccines that are known to cause ILD, no signal was observed. This study results might help decision-making on the subsequent COVID-19 vaccination strategy of ILD. Further large and prospective studies are required for more conclusive evidence.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • adverse drug
  • decision making
  • respiratory syndrome coronavirus
  • emergency department